Refine by
Biomarker Blood Articles & Analysis: Older
17 news found
BioMark’s blood-based biomarker panel has been selected to define personalized lung cancer risk assessment in Europe’s screen-eligible population who are most likely to benefit from a CT scan. ...
STALICLA’s unique approach addresses a major weakness in the drug development process for NDDs and neuropsychiatric disorders: behaviour is a terrible biomarker. Thanks to DEPI, a proprietary platform aggregating molecular data and human genetic information, STALICLA pushes the frontier of precision medicine further into precision NDDs. ...
BySTALICLA
“MDA is excited to support this work at Iron Horse Diagnostics, with the goal to address one of the most pressing challenges to ALS drug development — the need for prognostic biomarkers,” said MDA Scientific Program Officer Amanda M. Haidet-Phillips, Ph.D. ...
BynVector
In addition, the clinical improvement was associated with positive impact upon blood biomarkers (e.g. a decrease in muscle atrophy biomarkers and a normalization of metabolic biomarkers). ...
To be part of the EIC Accelerator is a big boost for the company and the commercialization of Amadix’ firs product, PREVECOL® (previously known as Colofast), a test for the early detection of colorectal cancer in blood combining biomarkers and artificial intelligence tools. Read the full new here ...
ByAmadix
In a separate development at CTAD, Suzanne Schindler, M.D., Ph.D., with Washington University School of Medicine, presented data from 1,085 individuals that showed the PrecivityAD™ blood test was highly concordant with CSF biomarkers and amyloid PET status in both cognitively normal (74% of those studied) and cognitively impaired (26%) individuals. The ...
Chagas can also be transmitted congenitally, via consumption of food contaminated by kissing bugs, and by blood transfusion or organ transplantation. Infection can lead to chronic disease lasting decades, with a higher risk of death due to cardiac or digestive system impairment; up to one third of infections result in debilitating symptoms, while the remainder are asymptomatic. ...
Reducing the number of unnecessary biopsies, increasing biopsy yield, and distinguishing high grade disease risk from low grade or benign disease with an effective blood test will be critical to savings lives, costs, and significantly improve overall patient ...
Its Solvent Interaction Analysis™ (SIA) technology investigates protein biomarkers in general circulation at the structural level (as opposed to overall biomarker concentration in blood), providing better and more direct insights regarding the protein origin on the cellular level, thus improving test specificity to the underlying disease ...
Through our ongoing partnership with QIAGEN, we also plan to develop complementary a biomarker diagnostic test that would enable practitioners to more effectively identify women expected to respond to VGX-3100." Biomarker Development In the course of the REVEAL 1 and REVEAL 2 clinical trials, INOVIO continues to pursue development of a pre-treatment RNA-based ...
Its Solvent Interaction Analysis™ (SIA) technology investigates protein biomarkers at the structural level (as opposed to overall biomarker concentration in blood), providing better and more direct insights regarding the protein biomarker origin on the cellular level, thus improving test specificity to the underlying ...
This is an important step towards the goal of developing a panel of metabolomics tests that could form the basis for a biological screen of risk for ASD. Analysis of other potential blood-based biomarkers using CAMP study samples is ongoing. Validation of additional metabotypes of ASD is expected to result in the ability to detect a still higher percentage of ...
DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, announced today a $492,000 award in support of the project entitled "Circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration." ...
ByDiamiR
Published studies from multicenter prospective clinical trials suggest that the non-invasive, blood-based IsoPSA assay has significant superior diagnostic accuracy when compared to traditional prostate-specific antigen (PSA) tests in detecting high-grade prostate cancer. ...
Key Findings and Conclusions: Safety demonstrated by the absence of injury to skin, internal organs or blood chemistries from repeated thermal treatments in a preclinical animal model. ...
” Challenge I Final Award Winners and their areas of research and innovation: Banyan Biomarkers, Inc. San Diego, Calif. - Banyan Biomarkers, Inc. is developing a point-of-care blood test to rapidly detect the presence of mild and moderate brain trauma to improve the medical management of head injured patients. ...
(NYSE: PKI ), a leading provider of drug discovery, life science research, and analytical solutions and Predictive Diagnostics, Inc., a wholly owned subsidiary of Large Scale Biology Corporation (NASDAQ: LSBC), announced today that they have found a series of biomarkers that appear to differ in persons with Alzheimer's Disease compared to persons without cognitive impairment, ...